This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Lawrence Livermore National Security, LLC, Merck Sharp + Dohme Corp., Epigen Biosciences, Inc.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017-2025
Title: The Innovations of Suk Joong Lee
Introduction
Suk Joong Lee is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of medicinal chemistry. With a total of six patents to his name, he has made remarkable strides in developing compounds that target critical enzymes involved in various diseases.
Latest Patents
Among his latest patents are the pyrimidine and pyridine amine compounds, which serve as enzyme p70S6K inhibitors. These compounds are particularly useful in treating S6K-dependent or S6K-mediated diseases and conditions, including cancer, fibrotic metabolic disorders, and certain neurological disorders. The innovative nature of these compounds highlights Suk Joong Lee's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Suk Joong Lee has worked with notable organizations, including Lawrence Livermore National Security, LLC and Merck Sharp & Dohme Corporation. His experience in these esteemed companies has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Suk Joong Lee has collaborated with talented individuals such as Daniel Bensen and Zhiyong Chen, who have played significant roles in his research endeavors. Their combined efforts have further propelled the development of innovative solutions in the field of disease treatment.
Conclusion
Suk Joong Lee's work exemplifies the impact of innovation in medicine, particularly through his patented compounds that target critical enzymes. His contributions continue to pave the way for advancements in the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile